Patient P-01639
Therapy response
Declining
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
8%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S02
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity-5
- Treatment adherence+5
- Toxicity-3
- Nutritional resilience-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion15.6/100
improving · -6.0 vs previous 14 d
Toxicity
Blood14.1/100
worsening · +1.8 vs previous 14 d
Sleep quality
Wearable56/100
improving · +3.7 vs previous 14 d
Energy level
Daily log6.9/10
stable · +0.3 vs previous 14 d
Stress level
Daily log2.7/10
improving · -0.7 vs previous 14 d
Steps
Wearable4,496
improving · +292 vs previous 14 d
Adherence
Companion100 %
stable · +0.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 92 from the failing basin, 7 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep histamine lowGI +2.9 next day on high-intake days · n 21
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Histamine load+2.9detractor · 95%
- Spicy / capsaicin+1.3no signal · 51%
- Insoluble fibre+0.4no signal · 15%
- Dietary fat load-0.2no signal · 15%
- Simple carbohydrates-0.2no signal · 15%
- Alcohol0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.8 · butyrate capacity 72/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 61 ms
- Sleep
- 6.8 h
- Steps
- 4,583
- Resting HR
- 62 bpm
Daily log: GI score 16, nutritional resilience 68, adherence 100.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01625 | 53% | S06 | SC-12 | improved | 83 |
| P-01439 | 51% | S18 | ME-01 | improved | 79 |
| P-01467 | 48% | S09 | HY-01 | improved | 79 |
| P-01329 | 47% | S08 | BR-03 | improved | 79 |
| P-01671 | 43% | S04 | SC-12 | improved | 90 |
| P-01479 | 41% | S15 | DT-01 | improved | 84 |
| P-01796 | 40% | S09 | SC-12 | improved | 86 |
| P-01654 | 39% | S08 | CR-01 | improved | 85 |
| P-01791 | 39% | S06 | ME-01 | improved | 79 |
| P-01798 | 39% | S08 | NP-02 | improved | 78 |
| P-01495 | 38% | S07 | BR-03 | improved | 85 |
| P-01855 | 38% | S04 | DT-01 | improved | 73 |